Nuformix PLC

NEW
FRA:1RT (UK)  
€ 0.00050 (0%) Jun 30
N/A
P/B:
2.00
Market Cap:
€ 5.45M ($ 6.20M)
Enterprise V:
€ 4.37M ($ 4.97M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Description
Nuformix PLC is a pharmaceutical development company. It operates in pharmaceutical development, targeting unmet medical needs in fibrosis and oncology through drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.88
Interest Coverage
No Debt
Piotroski F-Score
4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
9-Day RSI
0.03
14-Day RSI
2.01
6-1 Month Momentum %
-50
12-1 Month Momentum %
-50

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
4.32
Quick Ratio
4.32
Cash Ratio
4.1

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-48
Shareholder Yield %
-27.8

Profitability Rank

Name Current Vs Industry Vs History
ROE %
-58.42
ROA %
-47.68
ROIC %
-64.9
3-Year ROIIC %
-13.44
ROCE %
-59.17

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio
N/A
N/A
N/A
PE Ratio without NRI
N/A
N/A
N/A
PB Ratio
2
EV-to-EBIT
-5.96
EV-to-EBITDA
-6.1
EV-to-Forward-Revenue
167.55
EV-to-FCF
-6.93
Earnings Yield (Greenblatt) %
-16.77
FCF Yield %
-13.2

Financials (Next Earnings Date:2027-01-27 Est.)

FRA:1RT's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Nuformix PLC Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -
Beta 2.2309
3-Year Sharpe Ratio 0.33
3-Year Sortino Ratio 0.75
Volatility % 50
14-Day RSI 2.01
14-Day ATR (€) 0.000007
20-Day SMA (€) 0.0005
12-1 Month Momentum % -50
52-Week Range (€) 0.0005 - 0.019
Shares Outstanding (Mil) 2,609.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nuformix PLC Filings

Filing Date Document Date Form
No Filing Data

Nuformix PLC Stock Events

Financials Calendars
Event Date Price (€)
Second quarter earnings results for 2026 2026-05-28 0.00 (+0.00%)
General meeting for 2026 2026-03-03 08:30 0.00 (+0.00%)
Annual report for 2025 2026-02-13 0.00 (+0.00%)
Fourth quarter earnings results for 2025 2026-01-27 0.00 (+0.00%)
Second quarter earnings results for 2025 2025-05-02 0.00 (+0.00%)
General meeting for 2025 2025-03-20 10:00 0.00 (+0.00%)
Annual report for 2024 2025-02-14 0.00 (+0.00%)
Fourth quarter earnings results for 2024 2025-01-29 0.00 (+50.00%)
Show
Entries

Nuformix PLC Frequently Asked Questions

What is Nuformix PLC(FRA:1RT)'s stock price today?
The current price of FRA:1RT is €0.00. The 52 week high of FRA:1RT is €0.02 and 52 week low is €0.00.
When is next earnings date of Nuformix PLC(FRA:1RT)?
The next earnings date of Nuformix PLC(FRA:1RT) is 2027-01-27 Est..
Does Nuformix PLC(FRA:1RT) pay dividends? If so, how much?
Nuformix PLC(FRA:1RT) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Nuformix PLC

No articles.